PD-L1 expression in GVHD target tissues conferred protection from GVHD that was not shared in lymphohematopoietic tissue, where donor T cells are likely to encounter hematological neoplasms. This evidence concerns the gene CD274 and hematopoietic and lymphoid system neoplasm.